As a potent differentiation regulator, GM-CSF decelerates tumor progression by inducing terminal differentiation of cancer stem cells and cell cycle arrest at the G0/G1 phase in small cell lung cancer cell (SCLC) cell lines [18, 19]. Here, CSF2 is linked to neoplasm.